{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T23:29:04Z","timestamp":1792193344019,"version":"4.4.0"},"reference-count":34,"publisher":"Massachusetts Medical Society","issue":"17","license":[{"start":{"date-parts":[[2024,10,31]],"date-time":"2024-10-31T00:00:00Z","timestamp":1730332800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.nejmgroup.org\/legal\/terms-of-use.htm"}],"funder":[{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["N Engl J Med"],"published-print":{"date-parts":[[2024,10,31]]},"DOI":"10.1056\/nejmoa2400712","type":"journal-article","created":{"date-parts":[[2024,6,3]],"date-time":"2024-06-03T16:00:38Z","timestamp":1717430438000},"page":"1597-1609","source":"Crossref","is-referenced-by-count":285,"title":["Isatuximab, Bortezomib, Lenalidomide, and Dexamethasone for Multiple Myeloma"],"prefix":"10.1056","volume":"391","author":[{"given":"Thierry","family":"Facon","sequence":"first","affiliation":[{"name":"From the Department of Hematology, Centre Hospitalier Universitaire (CHU) de Lille, University of Lille, Lille (T.F., S. Manier), the French National Academy of Medicine (T.F.), and the Department of Hematology, H\u00f4pital Saint-Antoine, Sorbonne University and INSERM (M.M.), Paris, Service d\u2019H\u00e9matologie et Th\u00e9rapie Cellulaire, CHU and Centre d\u2019Investigation Clinique INSERM Unit\u00e9 1402, Poitiers (X.P.L.), the Department of Hematology, University Hospital H\u00f4tel-Dieu, Nantes (P.M.), and Sanofi, Research and Development, Vitry-sur-Seine (C.O., M.-F.B., S. Mac\u00e9, C.B.) \u2014 all in France; the Plasma Cell Dyscrasia Unit, Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens (M.-A.D.); the Department of Hematology, Ankara University, and the Istinye University Ankara Liv Hospital, Ankara (M.B.), and the Department of Internal Medicine, Istanbul Medical Faculty, Istanbul University, Istanbul (S.K.-B.) \u2014 all in Turkey; the Department of Internal Medicine, Hematology, and Oncology, Uni..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meletios-Athanasios","family":"Dimopoulos","sequence":"additional","affiliation":[{"name":"From the Department of Hematology, Centre Hospitalier Universitaire (CHU) de Lille, University of Lille, Lille (T.F., S. Manier), the French National Academy of Medicine (T.F.), and the Department of Hematology, H\u00f4pital Saint-Antoine, Sorbonne University and INSERM (M.M.), Paris, Service d\u2019H\u00e9matologie et Th\u00e9rapie Cellulaire, CHU and Centre d\u2019Investigation Clinique INSERM Unit\u00e9 1402, Poitiers (X.P.L.), the Department of Hematology, University Hospital H\u00f4tel-Dieu, Nantes (P.M.), and Sanofi, Research and Development, Vitry-sur-Seine (C.O., M.-F.B., S. Mac\u00e9, C.B.) \u2014 all in France; the Plasma Cell Dyscrasia Unit, Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens (M.-A.D.); the Department of Hematology, Ankara University, and the Istinye University Ankara Liv Hospital, Ankara (M.B.), and the Department of Internal Medicine, Istanbul Medical Faculty, Istanbul University, Istanbul (S.K.-B.) \u2014 all in Turkey; the Department of Internal Medicine, Hematology, and Oncology, Uni..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier P.","family":"Leleu","sequence":"additional","affiliation":[{"name":"From the Department of Hematology, Centre Hospitalier Universitaire (CHU) de Lille, University of Lille, Lille (T.F., S. Manier), the French National Academy of Medicine (T.F.), and the Department of Hematology, H\u00f4pital Saint-Antoine, Sorbonne University and INSERM (M.M.), Paris, Service d\u2019H\u00e9matologie et Th\u00e9rapie Cellulaire, CHU and Centre d\u2019Investigation Clinique INSERM Unit\u00e9 1402, Poitiers (X.P.L.), the Department of Hematology, University Hospital H\u00f4tel-Dieu, Nantes (P.M.), and Sanofi, Research and Development, Vitry-sur-Seine (C.O., M.-F.B., S. Mac\u00e9, C.B.) \u2014 all in France; the Plasma Cell Dyscrasia Unit, Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens (M.-A.D.); the Department of Hematology, Ankara University, and the Istinye University Ankara Liv Hospital, Ankara (M.B.), and the Department of Internal Medicine, Istanbul Medical Faculty, Istanbul University, Istanbul (S.K.-B.) \u2014 all in Turkey; the Department of Internal Medicine, Hematology, and Oncology, Uni..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meral","family":"Beksac","sequence":"additional","affiliation":[{"name":"From the Department of Hematology, Centre Hospitalier Universitaire (CHU) de Lille, University of Lille, Lille (T.F., S. Manier), the French National Academy of Medicine (T.F.), and the Department of Hematology, H\u00f4pital Saint-Antoine, Sorbonne University and INSERM (M.M.), Paris, Service d\u2019H\u00e9matologie et Th\u00e9rapie Cellulaire, CHU and Centre d\u2019Investigation Clinique INSERM Unit\u00e9 1402, Poitiers (X.P.L.), the Department of Hematology, University Hospital H\u00f4tel-Dieu, Nantes (P.M.), and Sanofi, Research and Development, Vitry-sur-Seine (C.O., M.-F.B., S. Mac\u00e9, C.B.) \u2014 all in France; the Plasma Cell Dyscrasia Unit, Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens (M.-A.D.); the Department of Hematology, Ankara University, and the Istinye University Ankara Liv Hospital, Ankara (M.B.), and the Department of Internal Medicine, Istanbul Medical Faculty, Istanbul University, Istanbul (S.K.-B.) \u2014 all in Turkey; the Department of Internal Medicine, Hematology, and Oncology, Uni..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludek","family":"Pour","sequence":"additional","affiliation":[{"name":"From the Department of Hematology, Centre Hospitalier Universitaire (CHU) de Lille, University of Lille, Lille (T.F., S. Manier), the French National Academy of Medicine (T.F.), and the Department of Hematology, H\u00f4pital Saint-Antoine, Sorbonne University and INSERM (M.M.), Paris, Service d\u2019H\u00e9matologie et Th\u00e9rapie Cellulaire, CHU and Centre d\u2019Investigation Clinique INSERM Unit\u00e9 1402, Poitiers (X.P.L.), the Department of Hematology, University Hospital H\u00f4tel-Dieu, Nantes (P.M.), and Sanofi, Research and Development, Vitry-sur-Seine (C.O., M.-F.B., S. Mac\u00e9, C.B.) \u2014 all in France; the Plasma Cell Dyscrasia Unit, Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens (M.-A.D.); the Department of Hematology, Ankara University, and the Istinye University Ankara Liv Hospital, Ankara (M.B.), and the Department of Internal Medicine, Istanbul Medical Faculty, Istanbul University, Istanbul (S.K.-B.) \u2014 all in Turkey; the Department of Internal Medicine, Hematology, and Oncology, Uni..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roman","family":"H\u00e1jek","sequence":"additional","affiliation":[{"name":"From the Department of Hematology, Centre Hospitalier Universitaire (CHU) de Lille, University of Lille, Lille (T.F., S. Manier), the French National Academy of Medicine (T.F.), and the Department of Hematology, H\u00f4pital Saint-Antoine, Sorbonne University and INSERM (M.M.), Paris, Service d\u2019H\u00e9matologie et Th\u00e9rapie Cellulaire, CHU and Centre d\u2019Investigation Clinique INSERM Unit\u00e9 1402, Poitiers (X.P.L.), the Department of Hematology, University Hospital H\u00f4tel-Dieu, Nantes (P.M.), and Sanofi, Research and Development, Vitry-sur-Seine (C.O., M.-F.B., S. Mac\u00e9, C.B.) \u2014 all in France; the Plasma Cell Dyscrasia Unit, Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens (M.-A.D.); the Department of Hematology, Ankara University, and the Istinye University Ankara Liv Hospital, Ankara (M.B.), and the Department of Internal Medicine, Istanbul Medical Faculty, Istanbul University, Istanbul (S.K.-B.) \u2014 all in Turkey; the Department of Internal Medicine, Hematology, and Oncology, Uni..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuogang","family":"Liu","sequence":"additional","affiliation":[{"name":"From the Department of Hematology, Centre Hospitalier Universitaire (CHU) de Lille, University of Lille, Lille (T.F., S. Manier), the French National Academy of Medicine (T.F.), and the Department of Hematology, H\u00f4pital Saint-Antoine, Sorbonne University and INSERM (M.M.), Paris, Service d\u2019H\u00e9matologie et Th\u00e9rapie Cellulaire, CHU and Centre d\u2019Investigation Clinique INSERM Unit\u00e9 1402, Poitiers (X.P.L.), the Department of Hematology, University Hospital H\u00f4tel-Dieu, Nantes (P.M.), and Sanofi, Research and Development, Vitry-sur-Seine (C.O., M.-F.B., S. Mac\u00e9, C.B.) \u2014 all in France; the Plasma Cell Dyscrasia Unit, Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens (M.-A.D.); the Department of Hematology, Ankara University, and the Istinye University Ankara Liv Hospital, Ankara (M.B.), and the Department of Internal Medicine, Istanbul Medical Faculty, Istanbul University, Istanbul (S.K.-B.) \u2014 all in Turkey; the Department of Internal Medicine, Hematology, and Oncology, Uni..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiri","family":"Minarik","sequence":"additional","affiliation":[{"name":"From the Department of Hematology, Centre Hospitalier Universitaire (CHU) de Lille, University of Lille, Lille (T.F., S. Manier), the French National Academy of Medicine (T.F.), and the Department of Hematology, H\u00f4pital Saint-Antoine, Sorbonne University and INSERM (M.M.), Paris, Service d\u2019H\u00e9matologie et Th\u00e9rapie Cellulaire, CHU and Centre d\u2019Investigation Clinique INSERM Unit\u00e9 1402, Poitiers (X.P.L.), the Department of Hematology, University Hospital H\u00f4tel-Dieu, Nantes (P.M.), and Sanofi, Research and Development, Vitry-sur-Seine (C.O., M.-F.B., S. Mac\u00e9, C.B.) \u2014 all in France; the Plasma Cell Dyscrasia Unit, Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens (M.-A.D.); the Department of Hematology, Ankara University, and the Istinye University Ankara Liv Hospital, Ankara (M.B.), and the Department of Internal Medicine, Istanbul Medical Faculty, Istanbul University, Istanbul (S.K.-B.) \u2014 all in Turkey; the Department of Internal Medicine, Hematology, and Oncology, Uni..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Moreau","sequence":"additional","affiliation":[{"name":"From the Department of Hematology, Centre Hospitalier Universitaire (CHU) de Lille, University of Lille, Lille (T.F., S. Manier), the French National Academy of Medicine (T.F.), and the Department of Hematology, H\u00f4pital Saint-Antoine, Sorbonne University and INSERM (M.M.), Paris, Service d\u2019H\u00e9matologie et Th\u00e9rapie Cellulaire, CHU and Centre d\u2019Investigation Clinique INSERM Unit\u00e9 1402, Poitiers (X.P.L.), the Department of Hematology, University Hospital H\u00f4tel-Dieu, Nantes (P.M.), and Sanofi, Research and Development, Vitry-sur-Seine (C.O., M.-F.B., S. Mac\u00e9, C.B.) \u2014 all in France; the Plasma Cell Dyscrasia Unit, Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens (M.-A.D.); the Department of Hematology, Ankara University, and the Istinye University Ankara Liv Hospital, Ankara (M.B.), and the Department of Internal Medicine, Istanbul Medical Faculty, Istanbul University, Istanbul (S.K.-B.) \u2014 all in Turkey; the Department of Internal Medicine, Hematology, and Oncology, Uni..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Romejko-Jarosinska","sequence":"additional","affiliation":[{"name":"From the Department of Hematology, Centre Hospitalier Universitaire (CHU) de Lille, University of Lille, Lille (T.F., S. Manier), the French National Academy of Medicine (T.F.), and the Department of Hematology, H\u00f4pital Saint-Antoine, Sorbonne University and INSERM (M.M.), Paris, Service d\u2019H\u00e9matologie et Th\u00e9rapie Cellulaire, CHU and Centre d\u2019Investigation Clinique INSERM Unit\u00e9 1402, Poitiers (X.P.L.), the Department of Hematology, University Hospital H\u00f4tel-Dieu, Nantes (P.M.), and Sanofi, Research and Development, Vitry-sur-Seine (C.O., M.-F.B., S. Mac\u00e9, C.B.) \u2014 all in France; the Plasma Cell Dyscrasia Unit, Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens (M.-A.D.); the Department of Hematology, Ankara University, and the Istinye University Ankara Liv Hospital, Ankara (M.B.), and the Department of Internal Medicine, Istanbul Medical Faculty, Istanbul University, Istanbul (S.K.-B.) \u2014 all in Turkey; the Department of Internal Medicine, Hematology, and Oncology, Uni..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Spicka","sequence":"additional","affiliation":[{"name":"From the Department of Hematology, Centre Hospitalier Universitaire (CHU) de Lille, University of Lille, Lille (T.F., S. Manier), the French National Academy of Medicine (T.F.), and the Department of Hematology, H\u00f4pital Saint-Antoine, Sorbonne University and INSERM (M.M.), Paris, Service d\u2019H\u00e9matologie et Th\u00e9rapie Cellulaire, CHU and Centre d\u2019Investigation Clinique INSERM Unit\u00e9 1402, Poitiers (X.P.L.), the Department of Hematology, University Hospital H\u00f4tel-Dieu, Nantes (P.M.), and Sanofi, Research and Development, Vitry-sur-Seine (C.O., M.-F.B., S. Mac\u00e9, C.B.) \u2014 all in France; the Plasma Cell Dyscrasia Unit, Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens (M.-A.D.); the Department of Hematology, Ankara University, and the Istinye University Ankara Liv Hospital, Ankara (M.B.), and the Department of Internal Medicine, Istanbul Medical Faculty, Istanbul University, Istanbul (S.K.-B.) \u2014 all in Turkey; the Department of Internal Medicine, Hematology, and Oncology, Uni..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladimir I.","family":"Vorobyev","sequence":"additional","affiliation":[{"name":"From the Department of Hematology, Centre Hospitalier Universitaire (CHU) de Lille, University of Lille, Lille (T.F., S. Manier), the French National Academy of Medicine (T.F.), and the Department of Hematology, H\u00f4pital Saint-Antoine, Sorbonne University and INSERM (M.M.), Paris, Service d\u2019H\u00e9matologie et Th\u00e9rapie Cellulaire, CHU and Centre d\u2019Investigation Clinique INSERM Unit\u00e9 1402, Poitiers (X.P.L.), the Department of Hematology, University Hospital H\u00f4tel-Dieu, Nantes (P.M.), and Sanofi, Research and Development, Vitry-sur-Seine (C.O., M.-F.B., S. Mac\u00e9, C.B.) \u2014 all in France; the Plasma Cell Dyscrasia Unit, Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens (M.-A.D.); the Department of Hematology, Ankara University, and the Istinye University Ankara Liv Hospital, Ankara (M.B.), and the Department of Internal Medicine, Istanbul Medical Faculty, Istanbul University, Istanbul (S.K.-B.) \u2014 all in Turkey; the Department of Internal Medicine, Hematology, and Oncology, Uni..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Britta","family":"Besemer","sequence":"additional","affiliation":[{"name":"From the Department of Hematology, Centre Hospitalier Universitaire (CHU) de Lille, University of Lille, Lille (T.F., S. Manier), the French National Academy of Medicine (T.F.), and the Department of Hematology, H\u00f4pital Saint-Antoine, Sorbonne University and INSERM (M.M.), Paris, Service d\u2019H\u00e9matologie et Th\u00e9rapie Cellulaire, CHU and Centre d\u2019Investigation Clinique INSERM Unit\u00e9 1402, Poitiers (X.P.L.), the Department of Hematology, University Hospital H\u00f4tel-Dieu, Nantes (P.M.), and Sanofi, Research and Development, Vitry-sur-Seine (C.O., M.-F.B., S. Mac\u00e9, C.B.) \u2014 all in France; the Plasma Cell Dyscrasia Unit, Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens (M.-A.D.); the Department of Hematology, Ankara University, and the Istinye University Ankara Liv Hospital, Ankara (M.B.), and the Department of Internal Medicine, Istanbul Medical Faculty, Istanbul University, Istanbul (S.K.-B.) \u2014 all in Turkey; the Department of Internal Medicine, Hematology, and Oncology, Uni..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadao","family":"Ishida","sequence":"additional","affiliation":[{"name":"From the Department of Hematology, Centre Hospitalier Universitaire (CHU) de Lille, University of Lille, Lille (T.F., S. Manier), the French National Academy of Medicine (T.F.), and the Department of Hematology, H\u00f4pital Saint-Antoine, Sorbonne University and INSERM (M.M.), Paris, Service d\u2019H\u00e9matologie et Th\u00e9rapie Cellulaire, CHU and Centre d\u2019Investigation Clinique INSERM Unit\u00e9 1402, Poitiers (X.P.L.), the Department of Hematology, University Hospital H\u00f4tel-Dieu, Nantes (P.M.), and Sanofi, Research and Development, Vitry-sur-Seine (C.O., M.-F.B., S. Mac\u00e9, C.B.) \u2014 all in France; the Plasma Cell Dyscrasia Unit, Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens (M.-A.D.); the Department of Hematology, Ankara University, and the Istinye University Ankara Liv Hospital, Ankara (M.B.), and the Department of Internal Medicine, Istanbul Medical Faculty, Istanbul University, Istanbul (S.K.-B.) \u2014 all in Turkey; the Department of Internal Medicine, Hematology, and Oncology, Uni..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wojciech","family":"Janowski","sequence":"additional","affiliation":[{"name":"From the Department of Hematology, Centre Hospitalier Universitaire (CHU) de Lille, University of Lille, Lille (T.F., S. Manier), the French National Academy of Medicine (T.F.), and the Department of Hematology, H\u00f4pital Saint-Antoine, Sorbonne University and INSERM (M.M.), Paris, Service d\u2019H\u00e9matologie et Th\u00e9rapie Cellulaire, CHU and Centre d\u2019Investigation Clinique INSERM Unit\u00e9 1402, Poitiers (X.P.L.), the Department of Hematology, University Hospital H\u00f4tel-Dieu, Nantes (P.M.), and Sanofi, Research and Development, Vitry-sur-Seine (C.O., M.-F.B., S. Mac\u00e9, C.B.) \u2014 all in France; the Plasma Cell Dyscrasia Unit, Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens (M.-A.D.); the Department of Hematology, Ankara University, and the Istinye University Ankara Liv Hospital, Ankara (M.B.), and the Department of Internal Medicine, Istanbul Medical Faculty, Istanbul University, Istanbul (S.K.-B.) \u2014 all in Turkey; the Department of Internal Medicine, Hematology, and Oncology, Uni..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sevgi","family":"Kalayoglu-Besisik","sequence":"additional","affiliation":[{"name":"From the Department of Hematology, Centre Hospitalier Universitaire (CHU) de Lille, University of Lille, Lille (T.F., S. Manier), the French National Academy of Medicine (T.F.), and the Department of Hematology, H\u00f4pital Saint-Antoine, Sorbonne University and INSERM (M.M.), Paris, Service d\u2019H\u00e9matologie et Th\u00e9rapie Cellulaire, CHU and Centre d\u2019Investigation Clinique INSERM Unit\u00e9 1402, Poitiers (X.P.L.), the Department of Hematology, University Hospital H\u00f4tel-Dieu, Nantes (P.M.), and Sanofi, Research and Development, Vitry-sur-Seine (C.O., M.-F.B., S. Mac\u00e9, C.B.) \u2014 all in France; the Plasma Cell Dyscrasia Unit, Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens (M.-A.D.); the Department of Hematology, Ankara University, and the Istinye University Ankara Liv Hospital, Ankara (M.B.), and the Department of Internal Medicine, Istanbul Medical Faculty, Istanbul University, Istanbul (S.K.-B.) \u2014 all in Turkey; the Department of Internal Medicine, Hematology, and Oncology, Uni..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gurdeep","family":"Parmar","sequence":"additional","affiliation":[{"name":"From the Department of Hematology, Centre Hospitalier Universitaire (CHU) de Lille, University of Lille, Lille (T.F., S. Manier), the French National Academy of Medicine (T.F.), and the Department of Hematology, H\u00f4pital Saint-Antoine, Sorbonne University and INSERM (M.M.), Paris, Service d\u2019H\u00e9matologie et Th\u00e9rapie Cellulaire, CHU and Centre d\u2019Investigation Clinique INSERM Unit\u00e9 1402, Poitiers (X.P.L.), the Department of Hematology, University Hospital H\u00f4tel-Dieu, Nantes (P.M.), and Sanofi, Research and Development, Vitry-sur-Seine (C.O., M.-F.B., S. Mac\u00e9, C.B.) \u2014 all in France; the Plasma Cell Dyscrasia Unit, Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens (M.-A.D.); the Department of Hematology, Ankara University, and the Istinye University Ankara Liv Hospital, Ankara (M.B.), and the Department of Internal Medicine, Istanbul Medical Faculty, Istanbul University, Istanbul (S.K.-B.) \u2014 all in Turkey; the Department of Internal Medicine, Hematology, and Oncology, Uni..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pawel","family":"Robak","sequence":"additional","affiliation":[{"name":"From the Department of Hematology, Centre Hospitalier Universitaire (CHU) de Lille, University of Lille, Lille (T.F., S. Manier), the French National Academy of Medicine (T.F.), and the Department of Hematology, H\u00f4pital Saint-Antoine, Sorbonne University and INSERM (M.M.), Paris, Service d\u2019H\u00e9matologie et Th\u00e9rapie Cellulaire, CHU and Centre d\u2019Investigation Clinique INSERM Unit\u00e9 1402, Poitiers (X.P.L.), the Department of Hematology, University Hospital H\u00f4tel-Dieu, Nantes (P.M.), and Sanofi, Research and Development, Vitry-sur-Seine (C.O., M.-F.B., S. Mac\u00e9, C.B.) \u2014 all in France; the Plasma Cell Dyscrasia Unit, Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens (M.-A.D.); the Department of Hematology, Ankara University, and the Istinye University Ankara Liv Hospital, Ankara (M.B.), and the Department of Internal Medicine, Istanbul Medical Faculty, Istanbul University, Istanbul (S.K.-B.) \u2014 all in Turkey; the Department of Internal Medicine, Hematology, and Oncology, Uni..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Zamagni","sequence":"additional","affiliation":[{"name":"From the Department of Hematology, Centre Hospitalier Universitaire (CHU) de Lille, University of Lille, Lille (T.F., S. Manier), the French National Academy of Medicine (T.F.), and the Department of Hematology, H\u00f4pital Saint-Antoine, Sorbonne University and INSERM (M.M.), Paris, Service d\u2019H\u00e9matologie et Th\u00e9rapie Cellulaire, CHU and Centre d\u2019Investigation Clinique INSERM Unit\u00e9 1402, Poitiers (X.P.L.), the Department of Hematology, University Hospital H\u00f4tel-Dieu, Nantes (P.M.), and Sanofi, Research and Development, Vitry-sur-Seine (C.O., M.-F.B., S. Mac\u00e9, C.B.) \u2014 all in France; the Plasma Cell Dyscrasia Unit, Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens (M.-A.D.); the Department of Hematology, Ankara University, and the Istinye University Ankara Liv Hospital, Ankara (M.B.), and the Department of Internal Medicine, Istanbul Medical Faculty, Istanbul University, Istanbul (S.K.-B.) \u2014 all in Turkey; the Department of Internal Medicine, Hematology, and Oncology, Uni..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hartmut","family":"Goldschmidt","sequence":"additional","affiliation":[{"name":"From the Department of Hematology, Centre Hospitalier Universitaire (CHU) de Lille, University of Lille, Lille (T.F., S. Manier), the French National Academy of Medicine (T.F.), and the Department of Hematology, H\u00f4pital Saint-Antoine, Sorbonne University and INSERM (M.M.), Paris, Service d\u2019H\u00e9matologie et Th\u00e9rapie Cellulaire, CHU and Centre d\u2019Investigation Clinique INSERM Unit\u00e9 1402, Poitiers (X.P.L.), the Department of Hematology, University Hospital H\u00f4tel-Dieu, Nantes (P.M.), and Sanofi, Research and Development, Vitry-sur-Seine (C.O., M.-F.B., S. Mac\u00e9, C.B.) \u2014 all in France; the Plasma Cell Dyscrasia Unit, Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens (M.-A.D.); the Department of Hematology, Ankara University, and the Istinye University Ankara Liv Hospital, Ankara (M.B.), and the Department of Internal Medicine, Istanbul Medical Faculty, Istanbul University, Istanbul (S.K.-B.) \u2014 all in Turkey; the Department of Internal Medicine, Hematology, and Oncology, Uni..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas G.","family":"Martin","sequence":"additional","affiliation":[{"name":"From the Department of Hematology, Centre Hospitalier Universitaire (CHU) de Lille, University of Lille, Lille (T.F., S. Manier), the French National Academy of Medicine (T.F.), and the Department of Hematology, H\u00f4pital Saint-Antoine, Sorbonne University and INSERM (M.M.), Paris, Service d\u2019H\u00e9matologie et Th\u00e9rapie Cellulaire, CHU and Centre d\u2019Investigation Clinique INSERM Unit\u00e9 1402, Poitiers (X.P.L.), the Department of Hematology, University Hospital H\u00f4tel-Dieu, Nantes (P.M.), and Sanofi, Research and Development, Vitry-sur-Seine (C.O., M.-F.B., S. Mac\u00e9, C.B.) \u2014 all in France; the Plasma Cell Dyscrasia Unit, Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens (M.-A.D.); the Department of Hematology, Ankara University, and the Istinye University Ankara Liv Hospital, Ankara (M.B.), and the Department of Internal Medicine, Istanbul Medical Faculty, Istanbul University, Istanbul (S.K.-B.) \u2014 all in Turkey; the Department of Internal Medicine, Hematology, and Oncology, Uni..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salomon","family":"Manier","sequence":"additional","affiliation":[{"name":"From the Department of Hematology, Centre Hospitalier Universitaire (CHU) de Lille, University of Lille, Lille (T.F., S. Manier), the French National Academy of Medicine (T.F.), and the Department of Hematology, H\u00f4pital Saint-Antoine, Sorbonne University and INSERM (M.M.), Paris, Service d\u2019H\u00e9matologie et Th\u00e9rapie Cellulaire, CHU and Centre d\u2019Investigation Clinique INSERM Unit\u00e9 1402, Poitiers (X.P.L.), the Department of Hematology, University Hospital H\u00f4tel-Dieu, Nantes (P.M.), and Sanofi, Research and Development, Vitry-sur-Seine (C.O., M.-F.B., S. Mac\u00e9, C.B.) \u2014 all in France; the Plasma Cell Dyscrasia Unit, Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens (M.-A.D.); the Department of Hematology, Ankara University, and the Istinye University Ankara Liv Hospital, Ankara (M.B.), and the Department of Internal Medicine, Istanbul Medical Faculty, Istanbul University, Istanbul (S.K.-B.) \u2014 all in Turkey; the Department of Internal Medicine, Hematology, and Oncology, Uni..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamad","family":"Mohty","sequence":"additional","affiliation":[{"name":"From the Department of Hematology, Centre Hospitalier Universitaire (CHU) de Lille, University of Lille, Lille (T.F., S. Manier), the French National Academy of Medicine (T.F.), and the Department of Hematology, H\u00f4pital Saint-Antoine, Sorbonne University and INSERM (M.M.), Paris, Service d\u2019H\u00e9matologie et Th\u00e9rapie Cellulaire, CHU and Centre d\u2019Investigation Clinique INSERM Unit\u00e9 1402, Poitiers (X.P.L.), the Department of Hematology, University Hospital H\u00f4tel-Dieu, Nantes (P.M.), and Sanofi, Research and Development, Vitry-sur-Seine (C.O., M.-F.B., S. Mac\u00e9, C.B.) \u2014 all in France; the Plasma Cell Dyscrasia Unit, Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens (M.-A.D.); the Department of Hematology, Ankara University, and the Istinye University Ankara Liv Hospital, Ankara (M.B.), and the Department of Internal Medicine, Istanbul Medical Faculty, Istanbul University, Istanbul (S.K.-B.) \u2014 all in Turkey; the Department of Internal Medicine, Hematology, and Oncology, Uni..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corina","family":"Oprea","sequence":"additional","affiliation":[{"name":"From the Department of Hematology, Centre Hospitalier Universitaire (CHU) de Lille, University of Lille, Lille (T.F., S. Manier), the French National Academy of Medicine (T.F.), and the Department of Hematology, H\u00f4pital Saint-Antoine, Sorbonne University and INSERM (M.M.), Paris, Service d\u2019H\u00e9matologie et Th\u00e9rapie Cellulaire, CHU and Centre d\u2019Investigation Clinique INSERM Unit\u00e9 1402, Poitiers (X.P.L.), the Department of Hematology, University Hospital H\u00f4tel-Dieu, Nantes (P.M.), and Sanofi, Research and Development, Vitry-sur-Seine (C.O., M.-F.B., S. Mac\u00e9, C.B.) \u2014 all in France; the Plasma Cell Dyscrasia Unit, Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens (M.-A.D.); the Department of Hematology, Ankara University, and the Istinye University Ankara Liv Hospital, Ankara (M.B.), and the Department of Internal Medicine, Istanbul Medical Faculty, Istanbul University, Istanbul (S.K.-B.) \u2014 all in Turkey; the Department of Internal Medicine, Hematology, and Oncology, Uni..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-France","family":"Br\u00e9geault","sequence":"additional","affiliation":[{"name":"From the Department of Hematology, Centre Hospitalier Universitaire (CHU) de Lille, University of Lille, Lille (T.F., S. Manier), the French National Academy of Medicine (T.F.), and the Department of Hematology, H\u00f4pital Saint-Antoine, Sorbonne University and INSERM (M.M.), Paris, Service d\u2019H\u00e9matologie et Th\u00e9rapie Cellulaire, CHU and Centre d\u2019Investigation Clinique INSERM Unit\u00e9 1402, Poitiers (X.P.L.), the Department of Hematology, University Hospital H\u00f4tel-Dieu, Nantes (P.M.), and Sanofi, Research and Development, Vitry-sur-Seine (C.O., M.-F.B., S. Mac\u00e9, C.B.) \u2014 all in France; the Plasma Cell Dyscrasia Unit, Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens (M.-A.D.); the Department of Hematology, Ankara University, and the Istinye University Ankara Liv Hospital, Ankara (M.B.), and the Department of Internal Medicine, Istanbul Medical Faculty, Istanbul University, Istanbul (S.K.-B.) \u2014 all in Turkey; the Department of Internal Medicine, Hematology, and Oncology, Uni..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandrine","family":"Mac\u00e9","sequence":"additional","affiliation":[{"name":"From the Department of Hematology, Centre Hospitalier Universitaire (CHU) de Lille, University of Lille, Lille (T.F., S. Manier), the French National Academy of Medicine (T.F.), and the Department of Hematology, H\u00f4pital Saint-Antoine, Sorbonne University and INSERM (M.M.), Paris, Service d\u2019H\u00e9matologie et Th\u00e9rapie Cellulaire, CHU and Centre d\u2019Investigation Clinique INSERM Unit\u00e9 1402, Poitiers (X.P.L.), the Department of Hematology, University Hospital H\u00f4tel-Dieu, Nantes (P.M.), and Sanofi, Research and Development, Vitry-sur-Seine (C.O., M.-F.B., S. Mac\u00e9, C.B.) \u2014 all in France; the Plasma Cell Dyscrasia Unit, Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens (M.-A.D.); the Department of Hematology, Ankara University, and the Istinye University Ankara Liv Hospital, Ankara (M.B.), and the Department of Internal Medicine, Istanbul Medical Faculty, Istanbul University, Istanbul (S.K.-B.) \u2014 all in Turkey; the Department of Internal Medicine, Hematology, and Oncology, Uni..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christelle","family":"Berthou","sequence":"additional","affiliation":[{"name":"From the Department of Hematology, Centre Hospitalier Universitaire (CHU) de Lille, University of Lille, Lille (T.F., S. Manier), the French National Academy of Medicine (T.F.), and the Department of Hematology, H\u00f4pital Saint-Antoine, Sorbonne University and INSERM (M.M.), Paris, Service d\u2019H\u00e9matologie et Th\u00e9rapie Cellulaire, CHU and Centre d\u2019Investigation Clinique INSERM Unit\u00e9 1402, Poitiers (X.P.L.), the Department of Hematology, University Hospital H\u00f4tel-Dieu, Nantes (P.M.), and Sanofi, Research and Development, Vitry-sur-Seine (C.O., M.-F.B., S. Mac\u00e9, C.B.) \u2014 all in France; the Plasma Cell Dyscrasia Unit, Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens (M.-A.D.); the Department of Hematology, Ankara University, and the Istinye University Ankara Liv Hospital, Ankara (M.B.), and the Department of Internal Medicine, Istanbul Medical Faculty, Istanbul University, Istanbul (S.K.-B.) \u2014 all in Turkey; the Department of Internal Medicine, Hematology, and Oncology, Uni..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Bregman","sequence":"additional","affiliation":[{"name":"From the Department of Hematology, Centre Hospitalier Universitaire (CHU) de Lille, University of Lille, Lille (T.F., S. Manier), the French National Academy of Medicine (T.F.), and the Department of Hematology, H\u00f4pital Saint-Antoine, Sorbonne University and INSERM (M.M.), Paris, Service d\u2019H\u00e9matologie et Th\u00e9rapie Cellulaire, CHU and Centre d\u2019Investigation Clinique INSERM Unit\u00e9 1402, Poitiers (X.P.L.), the Department of Hematology, University Hospital H\u00f4tel-Dieu, Nantes (P.M.), and Sanofi, Research and Development, Vitry-sur-Seine (C.O., M.-F.B., S. Mac\u00e9, C.B.) \u2014 all in France; the Plasma Cell Dyscrasia Unit, Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens (M.-A.D.); the Department of Hematology, Ankara University, and the Istinye University Ankara Liv Hospital, Ankara (M.B.), and the Department of Internal Medicine, Istanbul Medical Faculty, Istanbul University, Istanbul (S.K.-B.) \u2014 all in Turkey; the Department of Internal Medicine, Hematology, and Oncology, Uni..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zandra","family":"Klippel","sequence":"additional","affiliation":[{"name":"From the Department of Hematology, Centre Hospitalier Universitaire (CHU) de Lille, University of Lille, Lille (T.F., S. Manier), the French National Academy of Medicine (T.F.), and the Department of Hematology, H\u00f4pital Saint-Antoine, Sorbonne University and INSERM (M.M.), Paris, Service d\u2019H\u00e9matologie et Th\u00e9rapie Cellulaire, CHU and Centre d\u2019Investigation Clinique INSERM Unit\u00e9 1402, Poitiers (X.P.L.), the Department of Hematology, University Hospital H\u00f4tel-Dieu, Nantes (P.M.), and Sanofi, Research and Development, Vitry-sur-Seine (C.O., M.-F.B., S. Mac\u00e9, C.B.) \u2014 all in France; the Plasma Cell Dyscrasia Unit, Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens (M.-A.D.); the Department of Hematology, Ankara University, and the Istinye University Ankara Liv Hospital, Ankara (M.B.), and the Department of Internal Medicine, Istanbul Medical Faculty, Istanbul University, Istanbul (S.K.-B.) \u2014 all in Turkey; the Department of Internal Medicine, Hematology, and Oncology, Uni..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert Z.","family":"Orlowski","sequence":"additional","affiliation":[{"name":"From the Department of Hematology, Centre Hospitalier Universitaire (CHU) de Lille, University of Lille, Lille (T.F., S. Manier), the French National Academy of Medicine (T.F.), and the Department of Hematology, H\u00f4pital Saint-Antoine, Sorbonne University and INSERM (M.M.), Paris, Service d\u2019H\u00e9matologie et Th\u00e9rapie Cellulaire, CHU and Centre d\u2019Investigation Clinique INSERM Unit\u00e9 1402, Poitiers (X.P.L.), the Department of Hematology, University Hospital H\u00f4tel-Dieu, Nantes (P.M.), and Sanofi, Research and Development, Vitry-sur-Seine (C.O., M.-F.B., S. Mac\u00e9, C.B.) \u2014 all in France; the Plasma Cell Dyscrasia Unit, Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens (M.-A.D.); the Department of Hematology, Ankara University, and the Istinye University Ankara Liv Hospital, Ankara (M.B.), and the Department of Internal Medicine, Istanbul Medical Faculty, Istanbul University, Istanbul (S.K.-B.) \u2014 all in Turkey; the Department of Internal Medicine, Hematology, and Oncology, Uni..."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"150","reference":[{"key":"e_1_3_5_2_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-020-00359-2"},{"key":"e_1_3_5_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2020.11.014"},{"key":"e_1_3_5_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)31594-X"},{"key":"e_1_3_5_5_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-020-07503-y"},{"key":"e_1_3_5_6_2","doi-asserted-by":"publisher","DOI":"10.1080\/17474086.2020.1800451"},{"key":"e_1_3_5_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.14193"},{"key":"e_1_3_5_8_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2022017635"},{"key":"e_1_3_5_9_2","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2015.240"},{"key":"e_1_3_5_10_2","unstructured":"Sarclisa. Bridgewater NJ: Sanofi 2021 (https:\/\/products.sanofi.us\/Sarclisa\/sarclisa_patient_information.pdf)."},{"key":"e_1_3_5_11_2","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.22992"},{"key":"e_1_3_5_12_2","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.26590"},{"key":"e_1_3_5_13_2","unstructured":"Sanofi. Sarclisa highlights of prescribing information November 2023 (https:\/\/products.sanofi.us\/Sarclisa\/sarclisa.pdf)."},{"key":"e_1_3_5_14_2","unstructured":"Sarclisa INN-Isatuximab. Summary of product characteristics. 2021 (https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/sarclisa-epar-product-information_en.pdf )."},{"key":"e_1_3_5_15_2","unstructured":"Sarclisa (isatuximab). Prescribing information. 2021 (in Japanese) (https:\/\/www.pmda.go.jp\/drugs\/2021\/P20211111001\/780069000_30200AMX00511000_A100_1.pdf )."},{"key":"e_1_3_5_16_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2023-177546"},{"key":"e_1_3_5_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)31240-1"},{"key":"e_1_3_5_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(22)00263-0"},{"key":"e_1_3_5_19_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2312054"},{"key":"e_1_3_5_20_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1714678"},{"key":"e_1_3_5_21_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2019.37.15_suppl.TPS8056"},{"key":"e_1_3_5_22_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2023-179866"},{"key":"e_1_3_5_23_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-023-01936-7"},{"key":"e_1_3_5_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(16)30206-6"},{"key":"e_1_3_5_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(20)30452-6"},{"key":"e_1_3_5_26_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.23.01696"},{"key":"e_1_3_5_27_2","doi-asserted-by":"publisher","DOI":"10.1111\/ejh.13835"},{"key":"e_1_3_5_28_2","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.17499"},{"key":"e_1_3_5_29_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-11-568907"},{"key":"e_1_3_5_30_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2016.3160"},{"key":"e_1_3_5_31_2","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.14213"},{"key":"e_1_3_5_32_2","doi-asserted-by":"publisher","DOI":"10.1097\/HS9.0000000000000045"},{"key":"e_1_3_5_33_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1817249"},{"key":"e_1_3_5_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(21)00466-6"},{"key":"e_1_3_5_35_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1402551"}],"container-title":["New England Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nejm.org\/doi\/pdf\/10.1056\/NEJMoa2400712","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T18:37:21Z","timestamp":1749667041000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.nejm.org\/doi\/10.1056\/NEJMoa2400712"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,31]]},"references-count":34,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2024,10,31]]}},"alternative-id":["10.1056\/NEJMoa2400712"],"URL":"https:\/\/doi.org\/10.1056\/nejmoa2400712","relation":{},"ISSN":["0028-4793","1533-4406"],"issn-type":[{"value":"0028-4793","type":"print"},{"value":"1533-4406","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,31]]}}}